Search by Drug Name or NDC

    NDC 51655-0920-83 ATORVASTATIN CALCIUM 20 mg/1 Details

    ATORVASTATIN CALCIUM 20 mg/1

    ATORVASTATIN CALCIUM is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Northwind Pharmaceuticals, LLC. The primary component is ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE.

    Product Information

    NDC 51655-0920
    Product ID 51655-920_f76c6280-1141-9ad8-e053-6294a90aa16a
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name ATORVASTATIN CALCIUM
    Proprietary Name Suffix n/a
    Non-Proprietary Name ATORVASTATIN CALCIUM
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 20
    Active Ingredient Units mg/1
    Substance Name ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE
    Labeler Name Northwind Pharmaceuticals, LLC
    Pharmaceutical Class HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA090548
    Listing Certified Through 2024-12-31

    Package

    NDC 51655-0920-83 (51655092083)

    NDC Package Code 51655-920-83
    Billing NDC 51655092083
    Package 180 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-920-83)
    Marketing Start Date 2023-01-05
    NDC Exclude Flag N
    Pricing Information N/A